Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyRecruitingNot stated2025-10-22NCT07219927

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Supernus Pharmaceuticals, Inc.9

5 results · Page 1 of 1